Get Started
To learn more about how the NanoAssemblr Ignite and Ignite+ can accelerate preclinical drug development, contact a Scientific Specialist.
Contact a Specialist
LNP在NanoAssembler平台间放大生产时,其粒径、PDI和红细胞产生能力保持一致。A) 编码 EPO的 mRNA 被包裹在 LNPs 中,在不同生产平台产生的最高流速中有着相近的粒径与 PDI,显示出 NxGen 技术优秀的放大生产的能力。B) 用不同生产平台制备的 EPO-mRNA LNPs 被静脉注射进入老鼠体内,显示出相近的红细胞产生能力。
To learn more about how the NanoAssemblr Ignite and Ignite+ can accelerate preclinical drug development, contact a Scientific Specialist.
Contact a SpecialistPublication - Abstract
September 15, 2021
Vaccine
Publication - Abstract
August 19, 2021
Publication - Abstract
August 11, 2021
Advanced Science
Publication - Abstract
May 13, 2021
Nature Communications
Publication - Abstract
April 20, 2021
ACS Biomaterials Science & Engineering